New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For KMP;MERU;HNT;MTOR;CPNO;CHK;PLXT;ISIS;BIOC;BA;CODE;NOC;AMZN From The Last 14 Days
Check below for free stories on KMP;MERU;HNT;MTOR;CPNO;CHK;PLXT;ISIS;BIOC;BA;CODE;NOC;AMZN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
July 17, 2014
09:40 EDTAMZNActive equity options trading on open
Subscribe for More Information
07:10 EDTISISIsis Pharmaceuticals begins Phase 2 study of candidate for high lipoprotein(a)
Subscribe for More Information
06:50 EDTAMZNAirbus considering partnering with high tech companies, NY Times says
Subscribe for More Information
06:41 EDTBADefense Department to seek rival bids for satellite launches, WSJ reports
Subscribe for More Information
July 16, 2014
18:26 EDTKMPOn The Fly: After Hours Movers
Subscribe for More Information
17:04 EDTMTORMeritor initiated with an Overweight at Piper Jaffray
Subscribe for More Information
17:00 EDTKMPKinder Morgan Energy reports Q2 EPS ex-items 49c, consensus 55c
Subscribe for More Information
16:14 EDTKMPKinder Morgan Energy increases quarterly dividend by 5% to $1.39
Subscribe for More Information
16:00 EDTAMZNOptions Update; July 16, 2014
iPath S&P 500 VIX Short-Term Futures down 70c to 27.25. Option volume leaders: AAPL FB GOOG AMZN TWTR TSLA C HPQ TWX INTC AMZN according to Track Data.
10:58 EDTAMZNAmazon testing 'Kindle Unlimited' subscription service, Gigaom reports
Subscribe for More Information
09:35 EDTBAChina's 9 Air places $3.7B CFM engine order
Subscribe for More Information
09:09 EDTBAGeneral Electric-powered Boeing 777X commissioned by Qatar Airways
Subscribe for More Information
09:03 EDTBAQatar Airways commits to additional 50 GE9X-powered Boeing 777x
Subscribe for More Information
08:10 EDTBABoeing, Airbus narrow engine choices in move toward efficient jets, WSJ says
Subscribe for More Information
07:14 EDTISISIsis Pharmaceuticals earns $1M milestone payment from GlaxoSmithKline
Isis Pharmaceuticals (ISIS) has earned a $1M milestone payment from GlaxoSmithKline (GSK) related to the advancement of the Phase 2/3 study of ISIS-TTRRx in patients with familial amyloid polyneuropathy. ISIS-TTRRx is an antisense drug in development with GSK for the treatment of transthyretin amyloidosis, a severe and rare genetic disease characterized by progressive dysfunction of peripheral nerve and/or heart tissues. Including this milestone payment, Isis has generated $27M in upfront and milestone payments for advancing ISIS-TTRRx. If GSK elects to exercise its option to exclusively license the ISIS-TTRRx program, Isis is eligible to receive a license fee, regulatory and sales milestone payments and double-digit royalties on sales of ISIS-TTRRx.
06:47 EDTBABoeing Qatar Airways finalize order for 50 777Xs
Subscribe for More Information
06:40 EDTBABoeing, Hainan Airlines announce commitment for 50 737 MAX 8s
Subscribe for More Information
06:10 EDTBABoeing, MG Aviation finalize order for two 787-9 Dreamliners
Boeing and MG Aviation finalized an order for two additional 787-9 Dreamliners, valued at $499M at current list prices. The order will support the leasing company's growing fleet of modern airplanes. MG Aviation previously placed an order for two 787-9s in 2006 and now has four unfilled 787-9s orders.
05:56 EDTBABoeing, Air Algerie announce order for two Next-Generation 737-700Cs
Subscribe for More Information
05:50 EDTBABoeing rolls out 5,000th Next Generation 737
Boeing rolled out the 5,000th Next-Generation 737 this week. The airplane is a Boeing C-40A Clipper, a modified 737-700C, that will serve as a transport aircraft for the U.S. Navy. To date, orders stand at 6,804 for Next-Generation 737s and 2,109 for 737 MAXs. Total 737 orders have surpassed 12,000 including Classics and more than 100 orders for military derivatives.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use